BCN-Val-Cit-PAB-PNP CAS:2280920-96-7 is a small molecule drug that is composed of several functional groups. The BCN group is a type of cycloalkyne that is commonly used in bioconjugation reactions. The Val and Cit groups are amino acids that are commonly found in proteins and play important roles in biological processes. The PAB group is a para-aminobenzoic acid that can help to improve the solubility and stability of the drug in solution. The PNP group is a p-nitrophenyl group that can be used in enzymatic assays to detect the presence of the drug.
The combination of these functional groups in BCN-Val-Cit-PAB-PNP is designed to create a drug that can be used to target specific biological processes in the body. The Val and Cit groups, for example, are known to have significant activity against certain types of cancer cells, while the BCN and PAB groups can be used to conjugate the drug to other molecules such as antibodies or imaging agents for targeted drug delivery or diagnostic purposes. Overall, BCN-Val-Cit-PAB-PNP represents an important advance in the development of new drugs for the treatment of cancer and other diseases, and it holds significant promise for improving outcomes for patients in the future.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
